A machine learning lung cancer risk prediction model outperformed logistic regression, supporting improved risk assessment and more efficient radiology based lung cancer screening.

Noetik CEO and co-founder Ron Alfa, M.D., Ph.D., said the licensing of human foundation models is “a new paradigm in biotech.” With the GSK deal validating the paradigm, in Alfa’s view, Noetik ...

Please provide your email address to receive an email when new articles are posted on . Most Medicare beneficiaries did not have a shared decision-making (SDM) visit before their first lung cancer ...

A new study presented at the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer (WCLC) validates the use of Sybil, a deep learning artificial intelligence ...

Informed and shared decision-making is essential in lung cancer treatment, emphasizing clinical trial participation for advancing therapies. CheckMate 816 study showed improved overall survival with ...

Please provide your email address to receive an email when new articles are posted on . Many patients with lung cancer and their caregivers reported they lacked involvement in decision-making. Complex ...

A 60-year-old’s routine health screening revealed stage 1 lung cancer – a reminder that the disease can strike anyone, and ...

We currently know that COPD, and specifically emphysema, is not just a lung disease found alongside lung cancer; it increases ...